It has been reported that ANGPTL4 plays a role in epithelial-to-mesenchymal transition (EMT) in melanoma and ovarian cancer by regulating the ERK1/2 signaling pathways [57,58]. Here, ANGPTL4 is linked to ovarian carcinoma.